Title : Vildagliptin enhances islet responsiveness to both hyper- and hypoglycemia in patients with type 2 diabetes - Ahren_2009_J.Clin.Endocrinol.Metab_94_1236 |
Author(s) : Ahren B , Schweizer A , Dejager S , Dunning BE , Nilsson PM , Persson M , Foley JE |
Ref : J Clinical Endocrinology Metab , 94 :1236 , 2009 |
Abstract :
CONTEXT: Dipeptidyl peptidase-4 inhibitors act by increasing plasma levels of glucagon-like peptide-1 and suppressing excessive glucagon secretion in patients with type 2 diabetes. However, their effects on the glucagon response to hypoglycemia are not established. |
PubMedSearch : Ahren_2009_J.Clin.Endocrinol.Metab_94_1236 |
PubMedID: 19174497 |
Inhibitor | Vildagliptin |
Ahren B, Schweizer A, Dejager S, Dunning BE, Nilsson PM, Persson M, Foley JE (2009)
Vildagliptin enhances islet responsiveness to both hyper- and hypoglycemia in patients with type 2 diabetes
J Clinical Endocrinology Metab
94 :1236
Ahren B, Schweizer A, Dejager S, Dunning BE, Nilsson PM, Persson M, Foley JE (2009)
J Clinical Endocrinology Metab
94 :1236